Home  Contact Us
  Follow Us On:
 
Search:
Advertising Advertising Free Newsletter Free E-Newsletter
NEWS

Omicron rewrites the COVID plan for 2022
Published on: 2021-12-20
Share to
User Rating: / 0
PoorBest 

As the Omicron variant gains momentum in Europe and the United States, scientists are rewriting their expectations for the COVID-19 pandemic next year.
 

Just weeks ago, disease experts were predicting that countries would begin to emerge from the pandemic in 2022 after enduring a series of surges driven by the Alpha, Beta, Gamma and Delta variants. First among them would be populations with a significant amount of exposure to the coronavirus, through a combination of infections and vaccination.
 

In those places, COVID was expected to ease into an endemic disease, hopefully with less-severe periodic or seasonal outbreaks. Vaccines, available for much of 2021 only in wealthy nations, could reach the majority of the global population by the end of the year ahead.
 

But the rapid spread of the highly-mutated Omicron variant, identified in late November, and its apparent ability to reinfect people at a higher rate than its predecessors, is undermining that hope.
 

Already, countries are reverting to measures used earlier in the pandemic: restricting travel, reimposing mask requirements, advising against large gatherings for the winter holidays. While it is not quite back to square one, much more of the world will need to be vaccinated or exposed to COVID to get past the worst of the pandemic, disease experts said.
 

Even after COVID becomes a more endemic disease, new variants will spawn outbreaks and seasonal surges for years to come.
 

"There's always going to be a baseline number of COVID cases, hospitalizations and deaths," said Dr. Amesh Adalja, an infectious disease expert at the Johns Hopkins Center for Health Security. "A lot of people haven't come to terms with that."
 

The hope is that the virus diminishes to the point where it is no longer disruptive. But living with COVID-19 does not mean the virus is no longer a threat.
 

奥密克戎让科学家改写2022年对新冠的预期

近日,随着新冠变异病毒奥密克戎毒株在全球扩散,不少国家已宣布收紧防疫政策,将再度迎来一个难捱的新年。新毒株来势汹汹,新冠肺炎大流行是否有望在2022年结束?由于奥密克戎毒株带来的不确定性,部分科学家正在改写2022年对新冠疫情的预期。
 

就在几周前,全球疾病专家还在预测,在经历阿尔法、贝塔、德尔塔等一系列变异毒株引发的“感染浪潮”后,各国有望在2022年通过疫苗接种、群体免疫等方式逐渐摆脱大流行。
 

科学家还预计,部分地区新冠大流行(pandemic)将逐渐降至地方性流行(endemic)水平,这意味着新冠肺炎在部分地区将演变为不太严重的周期性或季节性疾病。与此同时,预计新冠疫苗2022年也将在全球大规模普及。
 

然而,11月下旬被首度报告的奥密克戎毒株却正在改写科学家的预期。
 

“人们已对这场大流行感到厌倦。”加拿大萨斯喀彻温大学传染病学专家安吉拉•拉斯穆森(angela rasmussen)说。但她表示,除非领导人能迅速采取行动,否则“2022年将会和2021年大同小异”。
 

科学家还警告称,即便新冠日后成为地方性流行病,也不意味着它不再是个威胁。新的变异毒株仍将在未来数年内引发地区聚集性和季节性感染激增。
 

约翰斯•霍普金斯大学健康安全中心流行病学专家阿梅什•阿达利亚(amesh adalja)警告称:“总会有一个基线数量的新冠感染、住院和死亡病例,但很多人并没有正视这一点。”

Comments (0)Add Comment

Write comment

security code
Write the displayed characters


busy
    Subscription    |     Advertising    |     Contact Us    |
Address: Magnetic Plaza, Building A4, 6th Floor, Binshui Xi Dao.
Nankai District. 300381 TIANJIN. PR CHINA
Tel: +86 22 23917700
E-mail: webmaster@businesstianjin.com
Copyright 2024 BusinessTianjin.com. All rights reserved.